- Peptide and protein quantification is a major component of quantitative proteomics that aims to determine the relative or absolute abundance of peptides and proteins in biological samples. While protein identification establishes which proteins are present, quantification measures how their abundance changes between tissues, cells, organisms, developmental stages, disease conditions, treatments, or experimental groups. These measurements help researchers understand biological regulation, identify biomarkers, investigate molecular pathways, and characterize changes in cellular and organismal physiology.
- In mass spectrometry-based proteomics, proteins are commonly digested into peptides using enzymes such as trypsin before analysis. The resulting peptides are separated by liquid chromatography and analyzed by mass spectrometry. Peptide abundance is estimated from measurable signals, including precursor-ion intensity, fragment-ion intensity, chromatographic peak area, or the number of identified spectra. Protein abundance is then inferred by combining quantitative information from peptides assigned to the same protein. Because several peptides may originate from one protein, peptide-level measurements provide the foundation for protein-level quantification.
- Peptide quantification involves measuring the abundance of individual peptide ions detected during a mass spectrometry experiment. In label-free quantification (LFQ), peptide abundance is commonly estimated from the intensity or integrated chromatographic peak area of a peptide ion across samples. Accurate quantification requires reliable peptide detection, retention-time alignment, peak integration, and correction for differences in sample loading and instrument response. Peptide signals can also be quantified using fragment-ion intensities in tandem mass spectrometry, particularly in data-independent acquisition (DIA) workflows. Spectral counting, which uses the number of tandem mass spectra assigned to a peptide or protein, provides another approach, although it is generally less precise than intensity-based methods for many applications.
- Protein quantification combines peptide-level measurements to estimate the abundance of individual proteins. Since a protein may generate multiple measurable peptides after enzymatic digestion, their signals can be summarized using methods such as summation, averaging, median intensity, or statistical models. Peptides that uniquely identify a protein are particularly useful for protein-specific quantification. Shared peptides, which occur in more than one protein or protein isoform, complicate abundance estimation because their signals cannot always be assigned unambiguously. Protein inference methods, peptide-to-protein grouping, and probabilistic models are therefore important for reliable protein quantification.
- Quantitative proteomics can be broadly divided into relative and absolute quantification. Relative quantification compares the abundance of peptides or proteins between samples or experimental conditions. It can identify proteins that increase or decrease in response to a treatment, disease, environmental change, or genetic variation. Absolute quantification estimates the actual amount or concentration of a protein or peptide, commonly using calibration standards, stable-isotope-labelled reference peptides, or validated quantitative assays. Relative quantification is widely used for large-scale comparative proteomics, whereas absolute quantification is valuable when precise molecular concentrations are required.
- Label-free quantification measures peptide and protein abundance without introducing chemical or isotopic labels. It generally uses precursor-ion intensities, chromatographic peak areas, or spectral counts. Its advantages include relatively simple sample preparation, flexibility, and the ability to analyze many samples independently. However, differences in sample preparation, chromatography, instrument performance, and missing peptide measurements can introduce technical variation. Normalization and quality-control procedures are therefore essential before comparing abundance across samples.
- Stable-isotope labelling introduces distinguishable isotopic forms of peptides or proteins so that samples can be compared through their mass spectrometric signals. In stable isotope labelling by amino acids in cell culture (SILAC), cells incorporate light or heavy isotopically labelled amino acids into newly synthesized proteins. After combining samples, corresponding peptide forms can be distinguished by their mass differences and quantified by comparing their signals. Chemical labelling approaches include tandem mass tags (TMT) and isobaric tags for relative and absolute quantification (iTRAQ). These reagents label peptides from different samples with chemically equivalent tags that produce distinct reporter ions during fragmentation. Multiplexed analysis allows several samples to be quantified within a single mass spectrometry experiment, although ratio compression and interference from co-isolated peptides can affect accuracy.
- Targeted proteomics provides a focused approach for quantifying selected peptides and proteins. Selected reaction monitoring (SRM), also called multiple reaction monitoring (MRM), measures predefined precursor-to-fragment ion transitions, typically using triple-quadrupole mass spectrometers. Parallel reaction monitoring (PRM) measures multiple fragment ions from selected precursor ions, commonly using high-resolution instruments. These methods offer high sensitivity, reproducibility, and specificity for validating candidate biomarkers or measuring proteins in defined biological pathways. Stable-isotope-labelled internal standards can improve accuracy and support absolute quantification.
- Data-independent acquisition (DIA) has become an important approach for large-scale peptide and protein quantification. In DIA, the mass spectrometer systematically fragments ions across predefined mass-to-charge windows rather than selecting only a limited number of precursor ions for fragmentation. The resulting complex fragment-ion data are analyzed using spectral libraries or computational prediction methods. DIA can provide reproducible measurements across large sample sets and reduce missing quantitative values compared with many traditional data-dependent acquisition (DDA) workflows. Software such as DIA-NN, Spectronaut, EncyclopeDIA, and Skyline supports peptide detection, signal extraction, and protein quantification in DIA experiments.
- Several computational steps are required to obtain reliable quantitative results. Raw mass spectrometry data are first processed to detect peptide features, identify spectra, extract ion intensities, and assign peptide sequences. Quantitative signals are then aligned across samples, filtered for reliability, and normalized to reduce technical variation. Common normalization approaches include total ion current normalization, median normalization, quantile normalization, and reference-based normalization. Batch-effect correction may also be required when samples are analyzed across different experimental runs, instrument batches, or laboratories. Missing values must be examined carefully because they may reflect low abundance, stochastic peptide detection, or technical failures rather than true biological absence.
- Statistical analysis is used to identify significant differences in peptide and protein abundance between experimental groups. Methods may include t-tests, analysis of variance (ANOVA), linear models, and empirical Bayes approaches. Multiple-testing correction is important because thousands of peptides and proteins may be evaluated simultaneously. False discovery rate (FDR) control and adjusted p-values help limit false-positive findings. Fold change, confidence intervals, and effect sizes provide additional information about the magnitude and reliability of abundance differences. Biological replicates are essential for estimating biological variability, while technical replicates help assess measurement consistency.
- Peptide and protein quantification also faces several challenges. Differences in protein digestion efficiency, peptide ionization, chromatographic separation, ion suppression, co-isolation interference, and instrument sensitivity can affect measured abundance. Peptides from the same protein may show different quantitative behavior because of post-translational modifications, missed cleavages, sequence variants, or differences in digestion and detection efficiency. Protein isoforms and homologous proteins can also complicate the assignment of peptide signals. Consequently, quantitative measurements should be interpreted alongside experimental design, quality-control metrics, protein inference results, and biological evidence.
- Quantitative proteomics has applications in disease research, biomarker discovery, drug development, pharmacology, immunology, microbiology, biotechnology, agriculture, and animal breeding. It can reveal changes in metabolic enzymes, signalling proteins, immune responses, stress-related proteins, and tissue-specific pathways. In animal breeding and agricultural research, peptide and protein quantification can help investigate the molecular basis of growth, feed efficiency, milk composition, meat quality, reproductive performance, disease resistance, and adaptation to environmental stress. Integrating quantitative proteomics with genomics, transcriptomics, metabolomics, and phenotypic data supports a more comprehensive understanding of genotype–phenotype relationships.
- Peptide and protein quantification therefore connects mass spectrometric measurements with biological interpretation. Reliable results depend on appropriate experimental design, accurate peptide identification, suitable quantification strategies, normalization, statistical analysis, and careful protein inference. Advances in high-resolution mass spectrometry, DIA, targeted proteomics, computational prediction, and statistical modelling continue to improve the sensitivity, reproducibility, and scale of quantitative proteomics.